Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell

Jean Mukherjee, Gabriel Nussbaum, Matthew D. Scharff, Arturo Casadevall

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

Two immunoglobulin M monoclonal antibodies (mAbs) derived from the same B cell recognize different epitopes on the capsular polysaccharide of the pathogenic yeast, Cryptococcus neoformans. Their respective epitopes are located in spatially distinct regions of the capsule. Passive administration of one mAb prolonged survival whereas the other mAb did not. The results indicate that specificity is an important determinant of antibody efficacy against C. neoformans and that somatic mutations occurring during the antibody response can affect the protective efficacy of antibodies to C. neoformans.

Original languageEnglish (US)
Pages (from-to)405-409
Number of pages5
JournalJournal of Experimental Medicine
Volume181
Issue number1
DOIs
StatePublished - Jan 1 1995

Fingerprint

Cryptococcus neoformans
B-Lymphocytes
Monoclonal Antibodies
Epitopes
Antibodies
Capsules
Antibody Formation
Polysaccharides
Immunoglobulin M
Yeasts
Mutation

ASJC Scopus subject areas

  • Immunology

Cite this

Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. / Mukherjee, Jean; Nussbaum, Gabriel; Scharff, Matthew D.; Casadevall, Arturo.

In: Journal of Experimental Medicine, Vol. 181, No. 1, 01.01.1995, p. 405-409.

Research output: Contribution to journalArticle

@article{4ef900846eb94444bdab39042d40cc9d,
title = "Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell",
abstract = "Two immunoglobulin M monoclonal antibodies (mAbs) derived from the same B cell recognize different epitopes on the capsular polysaccharide of the pathogenic yeast, Cryptococcus neoformans. Their respective epitopes are located in spatially distinct regions of the capsule. Passive administration of one mAb prolonged survival whereas the other mAb did not. The results indicate that specificity is an important determinant of antibody efficacy against C. neoformans and that somatic mutations occurring during the antibody response can affect the protective efficacy of antibodies to C. neoformans.",
author = "Jean Mukherjee and Gabriel Nussbaum and Scharff, {Matthew D.} and Arturo Casadevall",
year = "1995",
month = "1",
day = "1",
doi = "10.1084/jem.181.1.405",
language = "English (US)",
volume = "181",
pages = "405--409",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "1",

}

TY - JOUR

T1 - Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell

AU - Mukherjee, Jean

AU - Nussbaum, Gabriel

AU - Scharff, Matthew D.

AU - Casadevall, Arturo

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Two immunoglobulin M monoclonal antibodies (mAbs) derived from the same B cell recognize different epitopes on the capsular polysaccharide of the pathogenic yeast, Cryptococcus neoformans. Their respective epitopes are located in spatially distinct regions of the capsule. Passive administration of one mAb prolonged survival whereas the other mAb did not. The results indicate that specificity is an important determinant of antibody efficacy against C. neoformans and that somatic mutations occurring during the antibody response can affect the protective efficacy of antibodies to C. neoformans.

AB - Two immunoglobulin M monoclonal antibodies (mAbs) derived from the same B cell recognize different epitopes on the capsular polysaccharide of the pathogenic yeast, Cryptococcus neoformans. Their respective epitopes are located in spatially distinct regions of the capsule. Passive administration of one mAb prolonged survival whereas the other mAb did not. The results indicate that specificity is an important determinant of antibody efficacy against C. neoformans and that somatic mutations occurring during the antibody response can affect the protective efficacy of antibodies to C. neoformans.

UR - http://www.scopus.com/inward/record.url?scp=0028938643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028938643&partnerID=8YFLogxK

U2 - 10.1084/jem.181.1.405

DO - 10.1084/jem.181.1.405

M3 - Article

C2 - 7807020

AN - SCOPUS:0028938643

VL - 181

SP - 405

EP - 409

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 1

ER -